Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Fish and Richardson
US Army
Moodys
Chinese Patent Office
Johnson and Johnson

Generated: May 20, 2019

DrugPatentWatch Database Preview

Interferon beta-1a - Biologic Drug Details

« Back to Dashboard

Summary for interferon beta-1a
Tradenames:2
Patents:88
Applicants:2
BLAs:2
Suppliers: see list2
Pharmacology for interferon beta-1a

US Patents for interferon beta-1a

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Biogen AVONEX interferon beta-1a VIAL 103628 001 1996-05-17 ➤ Sign Up Pathologica LLC (San Francisco, CA) ➤ Sign Up RX search
Biogen AVONEX interferon beta-1a VIAL 103628 001 1996-05-17 ➤ Sign Up Avalyn Pharma Inc. (Seattle, WA) ➤ Sign Up RX search
Biogen AVONEX interferon beta-1a VIAL 103628 001 1996-05-17 ➤ Sign Up NOVIRA THERAPEUTICS, INC. (Doylestown, PA) ➤ Sign Up RX search
Biogen AVONEX interferon beta-1a VIAL 103628 001 1996-05-17 ➤ Sign Up ➤ Sign Up RX search
Biogen AVONEX interferon beta-1a VIAL 103628 001 1996-05-17 ➤ Sign Up UBE INDUSTRIES, LTD. (Yamaguchi, JP) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for interferon beta-1a

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2015 00060 Denmark ➤ Sign Up PRODUCT NAME: COBICISTAT ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/13/830/001-002 20130527
/2016 Austria ➤ Sign Up PRODUCT NAME: COBICISTAT ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON UND ATAZANAVIR ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON, INSBESONDERE ATAZANAVIR-SULFAT; REGISTRATION NO/DATE: EU/1/15/1025 (MITTEILUNG) 20150715
90003-6 Sweden ➤ Sign Up PRODUCT NAME: COBICISTAT OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF AND DARUNAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF, IN PARTICULAR DARUNAVIR ETHANOLATE; REG. NO/DATE: EU/1/14/967 20141121
2015040,C2049506 Lithuania ➤ Sign Up PRODUCT NAME: KOBICISTATAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA; REGISTRATION NO/DATE: EU/1/13/830/001 - 002 20130524
2016039 Lithuania ➤ Sign Up PRODUCT NAME: ATAZANAVIRAS + KOBICISTATAS; REGISTRATION NO/DATE: EU/1/15/1025 20150713
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
McKesson
US Army
Express Scripts
AstraZeneca
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.